(Q41970874)

English

Response: predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus (diabetes metab j 2011;35:159-65).

scientific article published on 30 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Response: predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus (diabetes metab j 2011;35:159-65). (English)

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Soon Ae Kim

1

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Woo Ho Shim

2

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Eun Hae Lee

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Young Mi Lee

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Sun Hee Beom

5

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Eun Sook Kim

6

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Jeong Seon Yoo

7

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Ji Sun Nam

8

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Min Ho Cho

9

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Jong Suk Park

10

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Chul Woo Ahn

11

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Kyung Rae Kim

12

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

publication date

30 June 2011

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Diabetes & metabolism journal

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

35

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

300-301

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Sitagliptin: a review of its use in the management of type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

5 June 2018

Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

5 June 2018

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

5 June 2018

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

Impact of sitagliptin on markers of beta-cell function: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138098

18 August 2018

Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21785752

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4093/DMJ.2011.35.3.300

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41970874&oldid=1869176263"